XML 20 R8.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common stock [Member]
Additional capital in excess of par value [Member]
Retained earnings [Member]
Accumulated other comprehensive income (loss) [Member]
Restricted shares [Member]
Restricted shares [Member]
Common stock [Member]
Restricted shares [Member]
Additional capital in excess of par value [Member]
Restricted stock units [Member]
Restricted stock units [Member]
Common stock [Member]
Restricted stock units [Member]
Additional capital in excess of par value [Member]
New accounting pronouncement, early adoption, effect [Member]
New accounting pronouncement, early adoption, effect [Member]
Additional capital in excess of par value [Member]
New accounting pronouncement, early adoption, effect [Member]
Retained earnings [Member]
Balances (in shares) at Dec. 31, 2014   261,110                        
Balances at Dec. 31, 2014 $ 5,395,200 $ 52,200 $ 756,500 $ 4,450,100 $ 136,400                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net income 1,223,000     1,223,000                    
Other comprehensive income (loss), net of tax (49,800)       (49,800)                  
Dividends declared (1,059,000)     (1,059,000)                    
Common stock-based compensation plans activity                            
Shares issued upon option exercises (shares)   2,471                        
Shares issued upon option exercises 84,500 $ 500 84,000                      
Shares issued, net of shares withheld for taxes (shares)             (180)     236        
Shares issued, net of shares withheld for taxes           $ (14,300)   $ (14,300) $ (2,000)   $ (2,000)      
Forfeiture of restricted awards (shares)   (59)                        
Net tax benefits 23,200   23,200                      
Stock-based compensation expense 149,000   149,000                      
Restricted stock units issued as dividend equivalents 0   200 (200)                    
Common shares repurchased (shares)   (13,109)                        
Common shares repurchased (987,800) $ (2,600) (342,000) (643,200)                    
Balances (in shares) at Dec. 31, 2015   250,469                        
Balances at Dec. 31, 2015 4,762,000 $ 50,100 654,600 3,970,700 86,600                  
Beginning balances attributable to redeemable non-controlling interests at Dec. 31, 2014 0                          
Increase (Decrease) in Temporary Equity [Roll Forward]                            
Net income attributable to redeemable non-controlling interests 0                          
Ending balances attributable to redeemable non-controlling interests at Dec. 31, 2015 0                          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Cumulative effect of adopting new accounting guidance | Accounting standards update 2015-2 [Member]       32,500 (32,500)                  
Cumulative effect of adopting new accounting guidance | Accounting standards update 2016-9 [Member]                       $ 3,900 $ 12,900 $ (9,000)
Balances, Adjusted 4,765,900 $ 50,100 667,500 3,994,200 54,100                  
Balances, Adjusted | Accounting standards update 2015-2 [Member]         54,100                  
Increase (Decrease) in Temporary Equity [Roll Forward]                            
Reclassification of T. Rowe Price investment products upon adoption of new accounting guidance on January 1, 2016 | Accounting standards update 2015-2 [Member] 672,700                          
Balances attributable to redeemable non-controlling interest, adjusted 672,700                          
Net income 1,215,000     1,215,000                    
Other comprehensive income (loss), net of tax (42,600)       (42,600)                  
Dividends declared (541,200)     (541,200)                    
Shares issued upon option exercises (shares)   4,140                        
Shares issued upon option exercises 149,500 $ 800 148,700                      
Shares issued, net of shares withheld for taxes (shares)             (178)     409        
Shares issued, net of shares withheld for taxes           (14,000)   (14,000) (8,700) $ 100 (8,800)      
Forfeiture of restricted awards (shares)   (61)                        
Stock-based compensation expense 161,600   161,600                      
Restricted stock units issued as dividend equivalents 0   100 (100)                    
Common shares repurchased (shares)   (9,995)                        
Common shares repurchased (676,900) $ (2,000) (300,600) (374,300)                    
Balances (in shares) at Dec. 31, 2016   244,784                        
Balances at Dec. 31, 2016 5,008,600 $ 49,000 654,500 4,293,600 11,500                  
Increase (Decrease) in Temporary Equity [Roll Forward]                            
Net income attributable to redeemable non-controlling interests 39,000                          
Other comprehensive loss, net of tax, attributable to reedemable non-controlling interests (2,500)                          
Net subscriptions into T. Rowe Price investment products 945,300                          
Net deconsolidations of T. Rowe Price investment products (967,300)                          
Ending balances attributable to redeemable non-controlling interests at Dec. 31, 2016 687,200                          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net income 1,497,800     1,497,800                    
Other comprehensive income (loss), net of tax (15,100)       (15,100)                  
Dividends declared (562,600)     (562,600)                    
Common stock-based compensation plans activity                            
Shares issued upon option exercises (shares)   6,339                        
Shares issued upon option exercises 252,200 $ 1,200 251,000                      
Shares issued, net of shares withheld for taxes (shares)             (170)     789        
Shares issued, net of shares withheld for taxes           $ (19,200)   $ (19,200) $ (31,200) $ 100 $ (31,300)      
Forfeiture of restricted awards (shares)   (19)                        
Forfeiture of restricted awards 0 $ 0 0                      
Stock-based compensation expense 152,000   152,000                      
Restricted stock units issued as dividend equivalents 0   200 (200)                    
Common shares repurchased (shares)   (6,612)                        
Common shares repurchased (458,100) $ (1,300) (161,100) (295,700)                    
Balances (in shares) at Dec. 31, 2017   245,111                        
Balances at Dec. 31, 2017 5,824,400 $ 49,000 $ 846,100 $ 4,932,900 $ (3,600)                  
Increase (Decrease) in Temporary Equity [Roll Forward]                            
Net income attributable to redeemable non-controlling interests 83,400                          
Other comprehensive loss, net of tax, attributable to reedemable non-controlling interests 21,200                          
Net subscriptions into T. Rowe Price investment products 1,243,700                          
Net deconsolidations of T. Rowe Price investment products (1,042,700)                          
Ending balances attributable to redeemable non-controlling interests at Dec. 31, 2017 $ 992,800